NewsBenzingaNovo Nordisk's Awiqli Receives FDA Approval As The First And Only Once-Weekly Insulin For Children 10 Years Of Age And Older With Type 2 Diabetes Novo Nordisk's Awiqli Receives FDA Approval As The First And Only Once-Weekly Insulin For Children 10 Years Of Age And Older With Type 2 Diabetes Benzinga 2026.10.23 18:24 (GMT+0) Open on Benzinga Other news US Stocks Face Earnings Peak and Fed Decision Next Week as AI Rally Is Tested Jensen Huang: AI Costs Are Falling 30 to 40 Times Per Year Tether's Mining Development Kit (MDK) Gains Support From 15 Organizations Including Bitmain and Canaan Weyerhaeuser Stock: Profound Mispricing (NYSE:WY) What You Need to Know Ahead of MetLife’s Earnings Release ExlService: A Boring Compounder That Could Double (NASDAQ:EXLS)
Tether's Mining Development Kit (MDK) Gains Support From 15 Organizations Including Bitmain and Canaan
